NASDAQ:ITOS

iTeos Therapeutics, Inc Earning Date

USA |NASDAQ |USD

ITOS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 10, 2021 Sep 2021 $4.95 $-0.75 $-0.48
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 10, 2021 Sep 2021 $161.12M $0.00 $0.00

Iteos Therapeutics, Inc's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 2021.

ITOS Earnings Date & History Chart

ITOS Earnings & Revenue Forecast

ITOS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.60 $-0.89 $-0.24
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $4.80 $-2.32 $12.87
Dec 2022 5 $-3.12 $-4.96 $-0.77

ITOS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.60 $-0.56 $-0.46
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $4.80 $-1.99 $-1.80
Dec 2022 0 / 0 $-3.12 $-2.63 $-2.22

ITOS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 5 $6.90M $0.00 $19.50M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $166.02M $0.00 $625.00M
Dec 2022 5 $27.62M $0.00 $78.12M

ITOS Earnings Date & Revenue History

ITOS Earnings History

|
Show More
Show More

ITOS Revenue History

|
Show More
Show More

Iteos Therapeutics, Inc Next Earnings Date & Report

ITOS Next Earnings Date & Report Preview: Sep 2021 (FQ)

ITOS's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 5 analysts, the average EPS estimation for Iteos Therapeutics, Inc's next quarterly earnings is $4.95, with a low EPS estimation of $-0.84, and a high estimation of $14.41.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $4.95, the last 2 month trend is $2.46, and the 3 month trend is $-0.47.

Based on 4 analysts, the average revenue estimation is $161.12M, with a low revenue estimation of $0.00, and a high estimation of $625.00M.

Iteos Therapeutics, Inc Previous Earnings Dates & Reports

ITOS Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Iteos Therapeutics, Inc's previous earnings date was Aug 11, 2021 for its fiscal quarter ended Jun 30, 2021.

ITOS's earnings per share (EPS) was $-0.75, missing the consensus analysts forecast of $-0.41 by -80.77%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 92.31%, and lower than the same period a year before (Jun 2020) by 154.32%.

Revenues were $0.00.

The company reported a net income of $-26.46M.

Free cash flow for the quarter was $-18.66M , compared to $-14.88M last quarter and $-10.09M a year before.

ITOS ended the quarter with $3.06M in total debt, an increase of 0.10% compared to the previous quarter.

ITOS Previous Earnings Date & Report Recap: Dec 2020 (FY)

Iteos Therapeutics, Inc's previous annual earnings date was Mar 24, 2021 for its fiscal year ended Dec 31, 2020.

ITOS's earnings per share (EPS) was $-1.20.

Revenues were $0.00.

The company reported a net income of $-38.03M.

Iteos Therapeutics, Inc reported a free cash flow of $-25.53M for its fiscal year, compared to $-23.87M a year ago.